http://purl.org/np/RA2HLBuzxo... RA2HLBuzxo

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0002-3668-2627 Elif Ozkan

Elif Ozkan

2022-10-13T13:24:20.435Z

http://purl.org/np/RA2HLBuzxo... RA2HLBuzxo

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-10-13T13:24:20.435129

Elif Ozkan

2022-10-13T13:24:20.435Z

http://purl.org/np/RA2HLBuzxo... RA2HLBuzxo

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

Theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. They are indicated to treat the symptoms of chronic asthma, other chronic diseases, such as emphysesma and broncitis, in addition to the symptoms associated with those with chronic lung disease.

Elif Ozkan

2022-10-13T13:24:20.435Z